Tracking plasma DNA mutation dynamics in estrogen receptor positive metastatic breast cancer with dPCR-SEQ
Sunil Kumar(Segeberger Kliniken), Gaorav P. Gupta(University of North Carolina at Chapel Hill), Lisa A. Carey(University of North Carolina at Chapel Hill), Xianming Tan(University of North Carolina at Chapel Hill), Q. Brent Chen(University of North Carolina at Chapel Hill), Carey K. Anders(Duke University), Amy Garrett(University of North Carolina at Chapel Hill), Daniel Lindsay(Royal Hospital Chelsea)
Cited by 42
Related Papers
The molecular portraits of breast tumors are conserved across microarray platforms
|BMC Genomics|2006|1.5k
Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer
|New England Journal of Medicine|2019|1.3k
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
|Annals of Oncology|2017|1.3k
Brain metastases
|Nature Reviews Disease Primers|2019|1.1k
Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline
|Journal of Clinical Oncology|2021|991